⌕
Universe Pharmaceuticals · UPC · Nasdaq
Tenet 62 · Solid
Compare
$1.56+5.41%At closeTenet 62 · Solid
$1.56+0.08 (+5.41%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Universe Pharmaceuticals (UPC) Stock

Universe Pharmaceuticals (UPC) closed at $1.56 on Nov 17, 2026; its Tenet Score is 62 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

34 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$1.56
Nov 17, 2026
Market cap
$674.7M
share price × the latest quarter's diluted weighted-average share count (vendor)
Tenet Score
62/100
Solid · 340 Healthcare peers

Industry: Drugs

Universe Pharmaceuticals INC scores 62/100. Solid. Strongest on value, quality is the soft spot versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
62/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
100
Quality
30
Health
60
Growth
59

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Momentum omitted — no data yet.
ValueA+QualityDHealthCGrowthCMomentum—
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
0.0×
fiscal year to Sep 30, 2025 · as of close, Nov 16, 2026
P/S
0.0×
price to sales, fiscal 2025 · as of close, Nov 16, 2026
ROE
−7%
fiscal year to Sep 30, 2025
Operating margin
−16.3%
before interest and tax
Net margin
−20.6%
fiscal year to Sep 30, 2025
Current ratio
4.07
fiscal year to Sep 30, 2025
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in t…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

CompanyTenet ScoreMarket cap
Lexicon Pharmaceuticals IncLXRX41$779.2M
Ardelyx IncARDX46$771.7M
Annexon IncANNX37$733.7M
Janux Therapeutics IncJANX74$668.1M
Kura Oncology IncKURA30$651.4M
Olema Oncology Inc.OLMA56$644.8M
Arbutus Biopharma CorpABUS58$619.3M
Cullinan Therapeutics IncCGEM55$616.7M
Geron Corp.GERN55$606.8M
Climb Bio Inc.CLYM62$583.9M

What sector and industry is Universe Pharmaceuticals in?

Universe Pharmaceuticals is in the Healthcare sector and the Drugs industry.

What is Universe Pharmaceuticals' Tenet Score?

Universe Pharmaceuticals' Tenet Score is 62 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.